Reaction

Stridor reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,907 reports · 85 co-occurring drugs

As of the last recalculation, Stridor appears in 2,907 FAERS reports alongside 85 co-occurring drug terms. The strongest observed disproportionality signal is SEVOFLURANE (PRR 27.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Sevoflurane	31	27.0	27.1
Tranexamic Acid	32	26.0	26.1
Oxaliplatin	235	24.6	24.7
Propofol	103	20.9	20.9
Ciclesonide	36	19.1	19.2
Iohexol	20	17.4	17.4
Cefazolin	18	14.2	14.2
Palivizumab	27	12.7	12.7
Cefazolin Sodium	21	12.6	12.6
Alteplase	23	11.0	11.1
Midazolam Hydrochloride	40	10.8	10.8
Rocuronium Bromide	17	10.4	10.4
Midazolam	36	10.3	10.4
Bupivacaine	13	10.0	10.0
Atropine	11	9.5	9.5
Gentamicin	17	9.4	9.4
Adrenalinum	53	9.3	9.3
Ampicillin	10	8.7	8.7
Ampicillin Sodium	10	8.7	8.7
Gentamicin Sulfate	19	8.7	8.7
Valproate Sodium	23	8.0	8.0
Atropine Sulfate	12	8.0	8.0
Epinephrine	70	7.8	7.8
Fentanyl	101	7.6	7.6
Ondansetron Hydrochloride	118	7.1	7.1
Ondansetron	103	7.0	7.0
Ondansetron Tablets	103	7.0	7.0
Naproxen Sodium Tablet, Coated	13	6.9	6.9
Naproxen Sodium, Coated Tablets	13	6.9	6.9
Naproxen Sodium 220Mg	13	6.9	6.9
Granisetron Hydrochloride	10	6.9	6.9
Acetylcysteine	9	6.9	6.9
Norepinephrine	10	6.7	6.7
Amantadine	14	6.5	6.5
Morphine	66	6.5	6.5
Theophylline Anhydrous	11	6.4	6.4
Piperacillin Sodium,Tazobactam Sodium	23	6.2	6.3
Anti-Thymocyte Globulin (Rabbit)	7	6.2	6.2
Magnesium Sulfate In Water For	11	6.2	6.2
Tretinoin	7	6.2	6.2
Granisetron	9	6.2	6.2
Lidicaine	41	6.1	6.1
Burn Relief	41	6.1	6.1
Magnesium Sulfate Heptahydrate	11	6.1	6.1
Lidocaine Hydrochloride And Epinephrine	41	6.1	6.1
Magnesium Sulfate	11	6.1	6.1
Capecitabine	75	6.0	6.0
Lidocaine, Menthol	41	6.0	6.0
Cetuximab	26	6.0	6.0
Lidocaine Hydrochloride And Epinephrine Bitartrate	44	6.0	6.0
Phenobarbital	12	5.9	6.0
Diphenhydramine Hcl	9	5.8	5.8
Tiotropium Bromide Inhalation Spray	9	5.8	5.8
Ceftriaxone	26	5.7	5.7
Fluorouracil Cream, 0.5%	59	5.6	5.6
Piperacillin And Tazobactam	10	5.6	5.6
Lidocaine 4%	42	5.6	5.6
Fluorouracil	59	5.6	5.6
Piperacillin Sodium And Tazobactam Sodium	15	5.5	5.5
Amlodipine Besylate And Benazepril Hydrochloride	7	5.4	5.4
Ceftriaxone Sodium	28	5.3	5.3
Iron Sucrose	7	5.3	5.3
Norepinephrine Bitartrate	10	5.0	5.0
Sodium Chloride Tablet	50	4.9	4.9
Sodium Chloride Tablets	50	4.9	4.9
Metoclopramide	36	4.7	4.7
Fosaprepitant Dimeglumine	9	4.7	4.7
Pegaspargase	8	4.7	4.7
Aprepitant	12	4.7	4.7
Agalsidase Beta	6	4.7	4.7
Botulinum Toxin Type A	8	4.6	4.6
Vigabatrin	9	4.4	4.4
Oseltamivir Phosphate	15	4.4	4.4
Fluticasone Furoate And Vilanterol Trifenatate	21	4.2	4.2
Omalizumab	48	4.1	4.1
Mepolizumab	26	3.8	3.8
Dabrafenib	10	3.4	3.4
Irinotecan Hydrochloride	6	3.3	3.3
Trametinib	10	3.0	3.0
Cisplatin	32	3.0	3.0
Panitumumab	6	2.7	2.7
Cenobamate	3	2.6	2.6
Axicabtagene Ciloleucel	3	2.2	2.2
Remdesivir	4	2.2	2.2
Droxidopa	6	2.0	2.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.